📣 Update from #ASCO26! Renowned experts share their views on new data emerging from the @ASCO Annual Meeting 👉 𝘏𝘌𝘙2-mutant NSCLC: Dr @herbloong & Dr @ipreeshagul data from SOHO-01, PRO data from Beamion LUNG-1, and more ~Endorsed by @WarOnCancer, @BiomarkerCo, @Exon20Group & @isliquidbiopsy (📺Video in this post! Slides also available: cor2ed.com/n-connect/program…) 👉 #NSCLC: Prof. @MarkSocinski reviews #LungCancer data from #LIBRETTO-432, WU-KONG28 & #HARMONi-6 ~Endorsed by International Cancer Advocacy Network, Biomarker Collaborative, Exon20 Group & International Society of Liquid Biopsy 👉 #ProstateCancer: Prof. Evan Yu reviews data from #PROTEUS & #TALAPRO-3 ~Endorsed by International Cancer Advocacy Network 👉 #ColorectalCancer, #PancreaticCancer & #LiverCancer: Prof. @HPrenen reviews data from #RASolute 302, #BREAKWATER & #EMERALD-3 ~Endorsed by International Cancer Advocacy Network & @dice_europe 👉 #BreastCancer: Dr @PtarantinoMD reviews data from #ASCENT-03, ASCENT-04, #TROPION-Breast02, #SERENA-6, #VIKTORIA-1, & #OPTIMA ~Endorsed by International Cancer Advocacy Network How will these data impact clinical practice? Watch the videos to find out! ▶️ cor2ed.com/n-connect/program… 𝘏𝘌𝘙2-mutant NSCLC update supported by an Independent Educational Grant from Bayer. All other updates supported by COR2ED. #MedEd #OncTwitter #MedTwitter #Oncology

Lung cancer 🫁 update from #ASCO26 👉 buff.ly/9P3rYdv Renowned lung cancer experts join our collaborators at COR2ED at ASCO 2026 to discuss breaking data emerging from the meeting. Watch the video updates for insights on HER2-mutant non-small cell lung cancer (NSCLC) from Drs Herbert Loong and Isabel Preeshagul, and analysis of other key lung cancer trial data from Prof. Mark Socinski. #LungCancer #NSCLC #SCLC @herbloong @ipreeshagul

GI and hepatobiliary cancer update from ASCO 2026 Medical oncologist Prof. Hans Prenen joins @COR2EDMedEd in Chicago to share his expert insights on the latest data in colorectal, pancreatic, and liver cancers presented at ASCO 2026. How will late-breaking data impact clinical practice? Watch his video update to find out. buff.ly/dSEZYZp

Breast Cancer Update from ASCO 2026 : Watch Dr @PTarantinoMD joins @COR2EDMedEd in Chicago to share his views on the latest breast cancer data emerging from ASCO 2026. How will new developments impact clinical practice? Watch his update to find out! buff.ly/iLLs16U

Dear Colleagues at #ASCO26 Get expert insights on new #ProstateCancer data emerging from ASCO 2026. Prof. Evan Yu joins @COR2EDMedEd live in Chicago to share his views on how new trial data presented at the meeting could impact the clinical management of patients with prostate cancer. Watch his conference update now. Watch here👉 cor2ed.com/asco-2026/prostat…

📣#GICancer highlights from #ASCO26! Prof. @HPrenen shares his expert insights on key #ColorectalCancer, #PancreaticCancer & #LiverCancer #trialdata from #EMERALD-3, #BREAKWATER & #RASolute 302 How will these data impact clinical practice? Watch his video to find out! 🤝 Programme endorsed by @WarOnCancer 📺See more updates from @ASCO in 𝘏𝘌𝘙2-mutant #NSCLC, #lungcancer, #ProstateCancer & #BreastCancer >> cor2ed.com/n-connect/program… This educational programme is supported by COR2ED #MedEd #HCC #CRCSM #CRC #CancerNurses

Lung cancer 🫁 update from #ASCO26 👉 buff.ly/aQLvoj5 Renowned lung cancer experts join our collaborators at @COR2EDMedEd at ASCO 2026 to discuss breaking data emerging from the meeting. Watch the video updates for insights on HER2-mutant non-small cell lung cancer (NSCLC) from Drs Herbert Loong and Isabel Preeshagul, and analysis of other key lung cancer trial data from Prof. Mark Socinski. #LungCancer #NSCLC #SCLC @herbloong @ipreeshagul

📢 #ASCO26 is nearly here, keep a look out for our conference update! In this video, Dr @ipreeshagul introduces the medical experts who will be joining us at ASCO ➡️Dr @herbloong: 𝘏𝘌𝘙2-mutant NSCLC (along with Dr Preeshagul) ➡️Prof. @MarkSocinski: #NSCLC / #LungCancer ➡️Prof. Evan Yu: #ProstateCancer ➡️Prof. @HPrenen: #GIcancer: #HCC, #LiverCancer, #CRC, #PanCan ➡️ Dr @PTarantinoMD: #BreastCancer 🎬 Keep checking back to see the videos as soon as they’re released: cor2ed.com/n-connect/program… 𝘏𝘌𝘙2-mutant NSCLC update supported by an Independent Educational Grant from Bayer. All other updates supported by COR2ED #MedEd #OncTwitter #OncMedEd

May is #OncologyNursingMonth 🩺 We want to recognise #cancernurses around the world, working tirelessly to provide the best care for their patients Thank you for all you do! 💐 From @COR2EDMedED, @GUNURSESCONNECT and GI NURSES CONNECT #IND26 #OncologyNursing

Useful insights on trial data, safety and real-world considerations for peri-operative immunotherapy in gastric and GEJ cancer. #MedEd

LEVIATHAN data indicate lenvatinib may offer greater second-line efficacy than sorafenib after atezolizumab plus bevacizumab in unresectable HCC, even in patients with primary resistance to immunotherapy.

We are proud to share that more than 50,000 HCPs around the world follow @COR2EDMedEd's programmes to stay up to date with the latest science, and provide their patients with the best possible care 🎉 ~ GI NURSES CONNECT is an initiative of COR2ED ~ 👏 Over 25k HCPs subscribe to the COR2ED YouTube channel to see educational videos as soon as they're released 👏 More than 25k followers stay up to date with #MedEd on the COR2ED social media channels on X, LinkedIn, Instagram, and BlueSky Are you part of our community yet? 🎓 Follow us for engaging videos, podcasts, publications, micro learnings, and more! Our programmes are developed by renowned medical experts and endorsed by Medical Societies & Patient Advocacy Groups ✅ Come and follow us on YouTube! youtube.com/@cor2edthehearto… #medicaleducation #MedTwitter #OncTwitter #GITwitter

🚨 New on-demand resources! 🚨 Expert insights from the latest gastric and gastroesophageal cancer data from ESMO 2025 📺 Newly-released video & slides from a virtual Experts Knowledge Share Meeting Chair: Dr @LizzySmyth1 (UK) Co-Chairs: Prof. Aziz Zaanan (France) & Prof. Markus Moehler (Germany) The faculty shares insights for clinical practice & discusses data from key clinical trials: ✔️ FORTITUDE-101 ✔️ INTEGRATE IIb ✔️ MATTERHORN ✔️ PHERFLOT ✔️ SKYSCRAPER-07 ✔️ LEAP-014 Get the slides: cor2ed.com/gi-connect/progra… 🤝 This programme is endorsed by @ESDO_tweets, @dice_europe & @WarOnCancer Supported by an Independent Educational Grant from Amgen #MedEd #MedTwitter #ESMO25

‘Peri-operative use of immunotherapy in gastric and GEJ cancer’ A new #MedEd video from Assoc. Prof. Sam Klempner📺 Get expert insights on the current treatment landscape, latest trial data, clinical impact, safety considerations, and more 🤝Endorsed by @WarOnCancer & Esophageal Cancer Action Network 🔗 View the slides: cor2ed.com/gi-connect/progra… Supported by an Independent Educational Grant from AstraZeneca US #RN #OncologyNursing

Gastric/gastroesophageal cancer data from #ESMO 2025: Experts Knowledge Share from @giconnectInfo! 🗓️ 19th November ⏰ 17:00 - 18:15 CET / 11:00 - 12:15 EST 🔗 Register now to secure your place! engage.cor2ed.com/events/esm… Join your peers in a post-ESMO interactive webinar to explore new data and the potential implications for clinical practice The panel will discuss what’s new for - targeted therapy & IO - the peri-operative space - esophageal squamous cell carcinoma (ESCC) 🗣️ PLUS: Q&A between speakers attendees Don’t miss it! 🤝Endorsed by: @dice_europe This independent programme is supported by an educational grant from Amgen #ESMO25 #MedEd #GIcancer #gastriccancer #ESMO2025 🎬

🎉 @COR2EDMedEd now has over 20,000 YouTube subscribers! 🎉 GI NURSES CONNECT is an initiative of COR2ED - come and find us on YouTube! Join over 20k healthcare professionals who follow us on YouTube to stay up to date with high-quality, engaging medical education programmes from world-renowned experts and in collaboration with Medical Societies and Patient Advocacy groups 🎓 Subscribe ▶️ youtube.com/@cor2edthehearto… #OncTwitter #MedTwitter #MedEd

📢Just released! Gastric & #gastroesophageal cancer update from #ESMO25! 📺 Dr @LizzySmyth1 shares her #gastric & GE cancer highlights & reviews the latest data from #MATTERHORN trial See more updates from #ESMO ▶️ cor2ed.com/n-connect/program… This independent programme is supported by COR2ED #MedEd #GastricCancer #GIcancer